These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32627074)

  • 21. Hallucinogens and Serotonin 5-HT
    López-Giménez JF; González-Maeso J
    Curr Top Behav Neurosci; 2018; 36():45-73. PubMed ID: 28677096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
    Moya PR; Berg KA; Gutiérrez-Hernandez MA; Sáez-Briones P; Reyes-Parada M; Cassels BK; Clarke WP
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1054-61. PubMed ID: 17337633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin 2A Receptor (5-HT
    Pottie E; Kupriyanova OV; Brandt AL; Laprairie RB; Shevyrin VA; Stove CP
    ACS Pharmacol Transl Sci; 2021 Apr; 4(2):479-487. PubMed ID: 33860178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoamine Transporter and Receptor Interaction Profiles in Vitro Predict Reported Human Doses of Novel Psychoactive Stimulants and Psychedelics.
    Luethi D; Liechti ME
    Int J Neuropsychopharmacol; 2018 Oct; 21(10):926-931. PubMed ID: 29850881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychedelic-inspired drug discovery using an engineered biosensor.
    Dong C; Ly C; Dunlap LE; Vargas MV; Sun J; Hwang IW; Azinfar A; Oh WC; Wetsel WC; Olson DE; Tian L
    Cell; 2021 May; 184(10):2779-2792.e18. PubMed ID: 33915107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform.
    Vasudevan L; Vandeputte M; Deventer M; Wouters E; Cannaert A; Stove CP
    Biochem Pharmacol; 2020 Jul; 177():113910. PubMed ID: 32179045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.
    Madsen MK; Fisher PM; Burmester D; Dyssegaard A; Stenbæk DS; Kristiansen S; Johansen SS; Lehel S; Linnet K; Svarer C; Erritzoe D; Ozenne B; Knudsen GM
    Neuropsychopharmacology; 2019 Jun; 44(7):1328-1334. PubMed ID: 30685771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
    Rickli A; Moning OD; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoamine receptor interaction profiles of 4-aryl-substituted 2,5-dimethoxyphenethylamines (2C-BI derivatives).
    Luethi D; Widmer R; Trachsel D; Hoener MC; Liechti ME
    Eur J Pharmacol; 2019 Jul; 855():103-111. PubMed ID: 31063768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychedelic-like Properties of Quipazine and Its Structural Analogues in Mice.
    de la Fuente Revenga M; Shah UH; Nassehi N; Jaster AM; Hemanth P; Sierra S; Dukat M; González-Maeso J
    ACS Chem Neurosci; 2021 Mar; 12(5):831-844. PubMed ID: 33400504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of the head-twitch response to investigate the structure-activity relationships of 4-thio-substituted 2,5-dimethoxyphenylalkylamines.
    Halberstadt AL; Luethi D; Hoener MC; Trachsel D; Brandt SD; Liechti ME
    Psychopharmacology (Berl); 2023 Jan; 240(1):115-126. PubMed ID: 36477925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychedelics and the human receptorome.
    Ray TS
    PLoS One; 2010 Feb; 5(2):e9019. PubMed ID: 20126400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo.
    Schmid CL; Raehal KM; Bohn LM
    Proc Natl Acad Sci U S A; 2008 Jan; 105(3):1079-84. PubMed ID: 18195357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards a quantitative representation of the cell signaling mechanisms of hallucinogens: measurement and mathematical modeling of 5-HT1A and 5-HT2A receptor-mediated ERK1/2 activation.
    Chang CW; Poteet E; Schetz JA; Gümüş ZH; Weinstein H
    Neuropharmacology; 2009; 56 Suppl 1(Suppl 1):213-25. PubMed ID: 18762202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro characterization of new psychoactive substances at the μ-opioid, CB1, 5HT
    Åstrand A; Guerrieri D; Vikingsson S; Kronstrand R; Green H
    Forensic Sci Int; 2020 Dec; 317():110553. PubMed ID: 33160102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Off-target activity of NBOMes and NBOMe analogs at the µ opioid receptor.
    Deventer MH; Persson M; Laus A; Pottie E; Cannaert A; Tocco G; Gréen H; Stove CP
    Arch Toxicol; 2023 May; 97(5):1367-1384. PubMed ID: 36853332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Machine learning
    Floresta G; Abbate V
    RSC Adv; 2021 Apr; 11(24):14587-14595. PubMed ID: 35424006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MAGI proteins can differentially regulate the signaling pathways of 5-HT
    Hammad MM; Dunn HA; Ferguson SSG
    Cell Signal; 2018 Jul; 47():109-121. PubMed ID: 29625175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors.
    Vargas MV; Dunlap LE; Dong C; Carter SJ; Tombari RJ; Jami SA; Cameron LP; Patel SD; Hennessey JJ; Saeger HN; McCorvy JD; Gray JA; Tian L; Olson DE
    Science; 2023 Feb; 379(6633):700-706. PubMed ID: 36795823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1.
    Rodriguiz RM; Nadkarni V; Means CR; Pogorelov VM; Chiu YT; Roth BL; Wetsel WC
    Sci Rep; 2021 Sep; 11(1):17690. PubMed ID: 34480046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.